COVID-19
Clinical guidelines
Haematopoietic Stem Cell Transplantation (HSCT)
The National Institute for Health and Care Excellence (NICE) have provided some guidance to maximise the safety of patients requiring HSCT while protecting staff from infection.
(published 2 April)
Thrombotic thrombocytopenic Purpura (TTP)
Prof. Marie Scully has provided an update on behalf of the TTP Network advising of the risks associated with COVID-19 in TTP patients
(published 2 April)
Sickle Cell and Thalassaemia
The Haemoglobinopathy Co-ordinating Centres have developed advice for the management of COVID-19 in patients with Sickle Cell Disease and Thalassaemia.
(published 23 March)
Operational updates
Patient website
Our patient-facing website is being regularly updated (published 2 April).
Risk mitigation
Our services are currently operating as per national guidance (such as Public Health England and NICE) and we are regularly reviewing operations with internal and external stakeholders. We are currently undertaking the following measures to ensure risks are minimised:
- If you wish to refer a patient positive for COVID-19, please discuss this with your TAS unit
- All staff members with symptoms of a new continuous cough or high temperature should stay at home and self-isolate
- TAS units should be kept up to date with your local Trust arrangements for management of the coronavirus
(published 23 March)